145 related articles for article (PubMed ID: 3514313)
1. Use of ceftazidime in febrile incidents in immunocompromised haematological patients.
d'Oliveira JJ; Pereira ME; Mateus LM; Monteiro JM; Parreira AS; Soares AD
J Int Med Res; 1986; 14(1):30-4. PubMed ID: 3514313
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of febrile episodes in neutropenic children by ceftazidime combined with netilmicin. Results of a multicenter study apropos of 88 cases].
Leverger G; Demeocq F; Harousseau JL; Taboureau O; Vannier JP; Boilletot A; de Lumley L; Boutard P; Olive D; Reinert P
Pathol Biol (Paris); 1987 May; 35(5):648-51. PubMed ID: 3302878
[TBL] [Abstract][Full Text] [Related]
3. Teicoplanin for therapy of gram-positive infections in neutropenic patients.
Verhagen C; De Pauw BE
Int J Clin Pharmacol Res; 1987; 7(6):491-8. PubMed ID: 2964418
[TBL] [Abstract][Full Text] [Related]
4. Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trial.
Harter C; Schulze B; Goldschmidt H; Benner A; Geiss HK; Hoppe-Tichy T; Ho AD; Egerer G
Bone Marrow Transplant; 2006 Feb; 37(4):373-9. PubMed ID: 16400334
[TBL] [Abstract][Full Text] [Related]
5. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
Tamura K
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
[TBL] [Abstract][Full Text] [Related]
6. Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors.
Kebudi R; Görgün O; Ayan I; Gürler N; Akici F; Töreci K
Med Pediatr Oncol; 2001 Apr; 36(4):434-41. PubMed ID: 11260566
[TBL] [Abstract][Full Text] [Related]
7. Should vancomycin be used empirically in febrile patients with prolonged and profound neutropenia? Results of a randomized trial.
Pico JL; Marie JP; Chiche D; Guiguet M; Andremont A; Lapierre V; Richet H; Tancrede C; Lagrange P; Hayat M
Eur J Med; 1993 May; 2(5):275-80. PubMed ID: 8252157
[TBL] [Abstract][Full Text] [Related]
8. [Imipenem/cilastatin versus ceftazidime-amikacin in the treatment of febrile neutropenic patients].
Pérez C; Sirham M; Labarca J; Grebe G; Lira P; Oliva J; Duhalde M; Ocqueteau M; Acuña G
Rev Med Chil; 1995 Mar; 123(3):312-20. PubMed ID: 8525170
[TBL] [Abstract][Full Text] [Related]
9. [Empirical antimicrobial therapy in neutropenic patients. Results of a multicenter study by the Infections in Hematology Study Group of the Paul Ehrlich Society].
Maschmeyer G; Link H; Hiddemann W; Meyer P; Helmerking M; Eisenmann E; Schmitt J; Adam D
Med Klin (Munich); 1994 Mar; 89(3):114-23. PubMed ID: 8196571
[TBL] [Abstract][Full Text] [Related]
10. [Infections in neutropenic children with neoplasms. Case series contribution].
Giacchino M; Artino RM; Miniero R; Grazia G; Vivalda M; Dotti G; Mattirolo F; Madon E
Minerva Pediatr; 1988 Jun; 40(6):339-44. PubMed ID: 3054471
[No Abstract] [Full Text] [Related]
11. Ceftazidime as initial therapy in febrile patients with acute leukemia during induction chemotherapy. Leukemia Group of Middle Sweden.
Samuelsson J; Lönnqvist B; Palmblad J; Grimfors G; Järnmark M; Lerner R; Ljungman P; Nyström-Rosander C; Oberg G
Scand J Infect Dis; 1992; 24(1):89-96. PubMed ID: 1589731
[TBL] [Abstract][Full Text] [Related]
12. A randomised dosage study of ceftazidime with single daily tobramycin for the empirical management of febrile neutropenia in patients with hematological diseases.
Gibson J; Johnson L; Snowdon L; Joshua D; Young G; MacLeod C; Iland H; Vincent P; Kronenberg H
Int J Hematol; 1994 Aug; 60(2):119-27. PubMed ID: 7948961
[TBL] [Abstract][Full Text] [Related]
13. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P
Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
[TBL] [Abstract][Full Text] [Related]
14. Infections in acute myeloid leukemia. Study of 184 febrile episodes.
Kumar L; Kochupillai V; Bhujwala RA
J Assoc Physicians India; 1992 Jan; 40(1):18-20. PubMed ID: 1634456
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of intravenous ceftazidime in childhood infections].
Kanra G; Gürsavaş M; Aydin M; Cengizlier R; Seçmeer G; Ceyhan M
Mikrobiyol Bul; 1990 Jul; 24(3):226-36. PubMed ID: 2283973
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of the combination of ceftazidime/vancomycin in the first line treatment of infection in neutropenic children].
Schaison G; Leverger G; Pappo M; Chiche D
Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):557-60. PubMed ID: 2200996
[TBL] [Abstract][Full Text] [Related]
17. Empiric antibiotic therapy with an amikacin-carbenicillin-cefoxitin combination in granulocytopenic febrile patients--a clinical report.
Fernández-Rañada J; Fernández-Garese D; Caretti D; Vázquez L; Escudero A; Olmeda F
Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):511-3. PubMed ID: 6642788
[TBL] [Abstract][Full Text] [Related]
18. [Combination of a 3d-generation cephalosporin (cefotaxime or ceftazidime) and a new quinolone (pefloxacine) in the treatment of febrile episodes in neutropenic diseases (37 cases)].
Guy H; Caillot D; Solary E; Bielefeld P; Portier H; Kazmierczak A
Presse Med; 1987 Dec; 16(43):2172-5. PubMed ID: 2963306
[TBL] [Abstract][Full Text] [Related]
19. [Therapy of febrile neutropenia episodes in systemic hematologic illnesses with new once daily ceftriaxone administration].
Karthaus M; Südhoff T; Fenchel K; Egerer G; Kämpfe D; Ritter J; Franke A; Heil G; Peters G; Jürgens H
Wien Med Wochenschr; 1998; 148(21):481-7. PubMed ID: 10048176
[TBL] [Abstract][Full Text] [Related]
20. Empiric monotherapy in neutropenia: a realistic goal?
Del Favero A; Bucaneve G; Menichetti F
Scand J Infect Dis Suppl; 1995; 96():34-7. PubMed ID: 7652501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]